Search Results 2251-2260 of 14813 for anti-TNF drugs

  1. Entrectinib (Oral Route) Precautions - Mayo Clinic

    Cancer medicines can cause constipation, diarrhea, nausea, or vomiting in most people, sometimes even after receiving medicines to prevent it. Ask your doctor ...

  2. A Study to Evaluate CTX110 in Subjects with Relapsed or Refractory B-Cell Malignancies - Mayo Clinic

    For NHL patients: Use of systemic anti-tumor therapy or investigational agent within 14 days or 5 half-lives, whichever is longer, of enrollment. For B cell ...

  3. Estradiol (Transdermal Route) Proper Use - Mayo Clinic

    Your doctor may adjust your dose as needed. Children—Use is not recommended. For the treatment of low estrogen levels: For transdermal dosage form (patch):.

  4. Iothalamate Meglumine (Injection Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  5. Efgartigimod Alfa And Hyaluronidase-Qvfc (Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Drugs and Supplements · Efgartigimod Alfa And ... anti-acetylcholine receptor (AChR) antibody positive. ... Drugs & Supplements; Efgartigimod Alfa And ...

  6. Indomethacin (Rectal Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  7. Probenecid (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  8. A Study to Evaluate ADP-A2M4 with Pembrolizumab to Treat Recurrent or Metastatic Head and Neck Cancer - Mayo Clinic

    ... treatment which was not successfully and rapidly clinically terminated with appropriate 1st-line anti-inflammatory therapy, will not be eligible. History of ...

  9. Antihistamine, Decongestant, And Anticholinergic Combination (Oral Route) Proper Use - Mayo Clinic

    The following information includes only the average doses of these medicines. If your dose is different, do not change it unless your doctor tells you to do so.

  10. Tezepelumab-Ekko (Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Tezepelumab-ekko injection is used together with other medicines to treat severe asthma. Tezepelumab-ekko helps prevent severe asthma attacks (exacerbations) ...